Regain control of drug spend in 2022: 3 pharmacy benefits trends to watch
As we near the end of the second pandemic year, the desire for quality and affordable health care has never been more top of mind.
The pandemic raised new concerns about medication access and supply, both of which drove utilization and costs upward. Centers for Medicare & Medicaid Services (CMS) projects prescription spend for commercial plans will grow an average of 5% annually, meanwhile, plan sponsors continue to battle budget pressures and ambiguity over their spend. And the benefit needs of member populations have changed because of the pandemic, once again putting pharmacy benefits under the microscope for 2022.
Read more by clicking the link to the full article below.

MORE ABOUT DAVID
David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain Navitus strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.